...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Market Woes
4
Apr 30, 2022 12:44AM
4
Apr 30, 2022 08:53AM
5
Apr 30, 2022 10:54AM
6
Apr 30, 2022 11:23AM
1
Apr 30, 2022 07:42PM
2
May 01, 2022 07:36AM
2
May 01, 2022 10:09AM

Koo ... one of the current problems is that this Omicron Covid is "no big deal" compared to Delta and the original. My sympathies to those that are still having severe issues with Covid though, there are still people dying, as with the flu. Omicron is just not "severe" to the average healthy person, it is highly contagious, and therefore is moving us quickly toward "herd immunity" but with high survival of the herd members.

I hate to say this, but this trial coulda/woulda been "money" had we gotten our "defecation consolidated" and did it back then when average healthy people were getting slammed hard. When EVERYONE was scared of Covid.

Where I am, in Ohio/Midwest, most people are rolling their eyes about Covid now, as an inconvenience. But just wait, for the next variant, right?! Could be worse, but Covid seems to be smartly evolving to less dangerous (except for certain population segments) -

I just got Covid this past week, felt like a mild-moderate cold. I actually felt like working rather than canceling customer apptointments, but I couldn't obviously. I am older and a smoker, and yes I realize I am just one person, but hearing the same thing from most of the reasonably "healthy" people experiencing Covid now. But again, no guarantees regarding future variants. And we do NEED a longer term solution.

Clever smart disease, it makes no sense to actually "kill" the hosts lolĀ 

That said, bigger impact of a positive Covid study and product, is

1) immediate help for those more vulnerable to Covid around the world - EUA?

2) longer term protection and confidence against whatever Covid shows up "next" down the road.

3) positive chatter re RVX/ABL - and we need newsworthy info, confidence and excitement, and word of mouth badly

4) futher validation on epigenetics and ABL in particular. Maybe a biger awareness, anticipation, and spotlight on BoM2.

I would expect a nice boost with positive Covid news, but probably not "all the way to the moon" reactions.

But, even if we boosted to ~ $1.00 that is 300% growth in price right now, and help to the portfolio re this particular stock. I'll take it, but hopefully a lot more.

Let's get BoM2 going please.

4
May 01, 2022 07:57PM
5
May 02, 2022 08:04PM
1
May 02, 2022 08:52PM
8
May 02, 2022 09:31PM
Share
New Message
Please login to post a reply